Literature DB >> 7599117

NMR solution structure of the RNA-binding peptide from human immunodeficiency virus (type 1) Rev.

M J Scanlon1, D P Fairlie, D J Craik, D R Englebretsen, M L West.   

Abstract

NMR spectroscopy has been used to solve the three-dimensional solution structure of a minimal RNA-binding domain of the Rev protein from the human immunodeficiency virus (type 1), an essential regulatory protein for viral replication. The presence of 10 arginine residues in the 17-residue peptide Rev34-50 caused significant problems in assignment of the NMR spectra. To improve spectral resolution, the peptide was synthesized with an alanine replacing a nonessential arginine and with selectively 15N-labeled residues. Contrary to Chou-Fasman modeling predictions an alpha-helix was detected in both water and 20% trifluoroethanol (TFE) and was found to span residues that constitute the RNA-binding and nuclear-localizing domains of Rev. The sequence-specific information provided by the NMR data gives a full description of the solution conformation of Rev34-50 which serves as a template for investigating binding of the peptide to RNA from the Rev response element (RRE). Preliminary modeling suggests that the helix can fit neatly into the expanded major groove of the RRE where interactions between the peptide side chains and the RNA can be identified. These data may aid the construction of a suitable pharmacophore model for the rational design of molecules that block Rev-RNA binding and inhibit HIV replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599117     DOI: 10.1021/bi00026a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Design and synthesis of type-III mimetics of omega-conotoxin GVIA.

Authors:  J B Baell; S A Forsyth; R W Gable; R S Norton; R J Mulder
Journal:  J Comput Aided Mol Des       Date:  2001-12       Impact factor: 3.686

2.  The arginine-rich RNA-binding motif of HIV-1 Rev is intrinsically disordered and folds upon RRE binding.

Authors:  Fabio Casu; Brendan M Duggan; Mirko Hennig
Journal:  Biophys J       Date:  2013-08-20       Impact factor: 4.033

3.  Intron positions correlate with module boundaries in ancient proteins.

Authors:  S J de Souza; M Long; L Schoenbach; S W Roy; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Preparation of oligoribonucleotides containing 4-thiouridine using Fpmp chemistry. Photo-crosslinking to RNA binding proteins using 350 nm irradiation.

Authors:  A McGregor; M V Rao; G Duckworth; P G Stockley; B A Connolly
Journal:  Nucleic Acids Res       Date:  1996-08-15       Impact factor: 16.971

Review 5.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

6.  Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency.

Authors:  Rosemary S Harrison; Nicholas E Shepherd; Huy N Hoang; Gloria Ruiz-Gómez; Timothy A Hill; Russell W Driver; Vishal S Desai; Paul R Young; Giovanni Abbenante; David P Fairlie
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

7.  Role of salt-bridging interactions in recognition of viral RNA by arginine-rich peptides.

Authors:  Lev Levintov; Harish Vashisth
Journal:  Biophys J       Date:  2021-10-26       Impact factor: 4.033

8.  Computational Studies of Intrinsically Disordered Proteins.

Authors:  Vy T Duong; Zihao Chen; Mahendra T Thapa; Ray Luo
Journal:  J Phys Chem B       Date:  2018-11-08       Impact factor: 2.991

9.  Binding stoichiometry and structural model of the HIV-1 Rev/importin β complex.

Authors:  Didier Spittler; Rose-Laure Indorato; Elisabetta Boeri Erba; Elise Delaforge; Luca Signor; Simon J Harris; Isabel Garcia-Saez; Andrés Palencia; Frank Gabel; Martin Blackledge; Marjolaine Noirclerc-Savoye; Carlo Petosa
Journal:  Life Sci Alliance       Date:  2022-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.